drugset / Trial / NCT00979004
A Study to Investigate the Effect of ICA-105665 in Photosensitive Epilepsy Patients
RandomizedCrossoverSingle-blindTreatment
Summary
Subjects with epilepsy with a documented photoparoxysmal response to intermittent photic stimulation (IPS) will participate. Four subjects will be enrolled at each dose level and will receive a single dose of placebo and a single dose of ICA-105665 during the study, each followed by intermittent photic stimulation. The effects of ICA-105665 on the photoparoxysmal electroencephalography (EEG) response of each group will be reviewed before the dose is selected for each subsequent group of subjects.
Timeline
- Start
- 2009-09
- Primary completion
- 2010-09
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ICA-105665 | Unknown | 50 mg | Oral |
| Subject | ICA-105665 | Unknown | 100 mg | Oral |